Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released May 6, 2021, after the close
10-Q filed May 6, 2021, 36 days after period end · 0000320017-21-000067
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Net Income | -$8.06M | -$3.99M | -$4.37M | -$4.98M |
| EPS Diluted | -$0.19 | -$0.38 | -$0.44 | -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
